Skip to main content
SpringerLink
Log in

Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists

  • ESCP Best Practice
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background Optimizing therapy regimens through collaboration and combination of available resources is a promising approach to improve quality of life for patients with Parkinson’s disease (PD). Aim The aim of this project was to enhance patient-oriented therapy and interprofessional collaboration by establishing a regional PD network. Setting The network is located in a rural area in Germany. It covers primary, secondary and tertiary care facilities across professional boundaries. Development Recruitment of PD specialists and patient support groups was done by the local newspaper to spread the word. The network was initially open to all healthcare professionals, who stated a focus or special interest in PD. A working group for medication was founded within the network by asking for interested participants. Problems in the medication process were discussed within the group. As a consequence, therapy recommendations (quickcards) and a specific medication plan were developed and a certified education curriculum for pharmacists was developed. Implementation The network grew to > 150 participants across all disciplines and sectors. Quickcards were adjusted, approved and implemented by the network during interquartile meetings. Certified education was implemented and became a requirement for participating pharmacists. Evaluation The quickcards on medication plan and drug-drug-interactions were approved to be useful and feasible by the network by unanimous assent. Overall satisfaction with certified education was high (mean of 1.4 on a scale between 1 = high and 6 = low). Conclusion A regional interprofessional PD network with pharmacists was established and new standards were established. Future research needs to measure the effects on patient outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Availability of data and material

All data and materials are available from the corresponding author upon reasonable request.

References

  1. Hsieh V, Paull G, Hawkshaw B. Heart Failure Integrated Care Project: overcoming barriers encountered by primary health care providers in heart failure management. Aust Health Rev. 2020;44:451–8.

    Article  Google Scholar 

  2. Community-based care for the specialized management of heart failure: an evidence-based analysis. Ont Health Technol Assess Ser. 2009;9:1–42.

  3. Wagner EH. Organizing care for patients with chronic illness revisited. Milbank Q. 2019;97:659–64.

    Article  Google Scholar 

  4. Bloem BR, Henderson EJ, Dorsey ER, Okun MS, Okubadejo N, Chan P, et al. Integrated and patient-centred management of Parkinson’s disease: a network model for reshaping chronic neurological care. Lancet Neurol. 2020;19:623–34.

    Article  Google Scholar 

  5. Bloem BR, Rompen L, Vries NMd, Klink A, Munneke M, Jeurissen P. ParkinsonNet: A Low-Cost Health Care Innovation With A Systems Approach From The Netherlands. Health Aff (Millwood). 2017;36:1987–96.

  6. Schröder S, Martus P, Odin P, Schaefer M. Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson’s disease. Int J Clin Pharm. 2012;34:746–56.

    Article  Google Scholar 

  7. Henrichsmann M, Hempel G. Impact of medication therapy management in patients with Parkinson’s disease. Int J Clin Pharm. 2016;38:54–60.

    Article  Google Scholar 

  8. Imfeld-Isenegger TL, Soares IB, Makovec UN, Horvat N, Kos M, van Mil F, et al. Community pharmacist-led medication review procedures across Europe: characterization, implementation and remuneration. Res Soc Adm Pharm. 2020;16:1057–66.

    Article  Google Scholar 

  9. Rose O, Derendorf H, Erzkamp S, Fujita K, Hartl A, Hoti K, et al. Development of clinical pharmacy services in Australia, Austria, Belgium, Bosnia-Herzegovina, Canada, Germany, Japan, Kosovo, Switzerland, the Netherlands, Thailand, USA and correlation with educational standards, level of research, and implemen. Int J Clin Pharmacol Ther. 2018;56:518–30.

    Article  Google Scholar 

  10. Stuhec M, Bratović N, Mrhar A. Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: A prospective non-randomized study. Sci Rep. 2019;9:16856.

    Article  Google Scholar 

  11. Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19:118.

    Article  Google Scholar 

  12. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.

    Article  Google Scholar 

  13. Kerkemeyer L, Achtert K, Claus I, Happe S, Overbeck J, Kleen N, et al. Quickcard-based approach to guiding specific nonpharmacological treatments in a German Parkinson‘s network. J Clin Med. 2020;17(9):2272.

    Article  Google Scholar 

  14. Dormann H, Maas R, Eickhoff C, Müller U, Schulz M, Brell D, et al. Standardized national medication plan : the pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:1093–102.

    Article  Google Scholar 

  15. Patel T, Chang F. Parkinson’s disease guidelines for pharmacists. Can Pharm J (Ott). 2014;147:161–70.

    Article  Google Scholar 

  16. Azmi H, Cocoziello L, Harvey R, McGee M, Desai N, Thomas J, et al. Development of a Joint Commission Disease-Specific Care Certification Program for Parkinson Disease in an Acute Care Hospital. J Neurosci Nurs. 2019;51:313–9.

    Article  Google Scholar 

Download references

Acknowledgements

The authors need to thank Prof. Dr. Daniela Berg, Friedrich Wilhelm Mehrhoff, Gabriele Regina Overwiening, Dr. Sabrina Schröder and Dr. Andreas Walter for their valuable support and contributions in establishing the board-certified education, Anke Vöcking and Antje Altekruse for valuable contributions in the working group and Stefanie Springer and Julia Stern for their eminent role in developing the quickcards and their contributions to the network.

Funding

This research received no external funding.

Author information

Authors and Affiliations

  1. Impac2t Research, Maximilianstr. 31-33, Münster, Germany

    Olaf Rose & Susanne Erzkamp

  2. Klinik Maria Frieden Telgte, Telgte, Germany

    Svenja Happe

  3. Department of Neurology, University of Münster, Münster, Germany

    Tessa Huchtemann, Constanze Mönig & Tobias Warnecke

  4. Klinik für Neurologie mit Klinischer Neurophysiologie, Herz-Jesu-Krankenhaus Hiltrup, Westfalenstr. 109, Münster, Germany

    Michael Ohms

  5. Apothekerkammer Westfalen-Lippe, Münster, Germany

    Oliver Schwalbe

Authors
  1. Olaf Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Svenja Happe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tessa Huchtemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Constanze Mönig
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Ohms
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Oliver Schwalbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tobias Warnecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Susanne Erzkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Olaf Rose.

Ethics declarations

Conflicts of interest

Susanne Erzkamp has received a speaker honorarium from MSD Sharp & Dohme, Svenja Happe has received lecturer honoraria from Bial, Bioprojet and Bayer Vital, Tessa Huchtemann declares that she has no competing interests, Constanze Mönig declares that she has no competing interests, Michael Ohms declares that he has no competing interests, Oliver Schwalbe declares that he has no competing interests, Olaf Rose has received a speaker honorarium from AbbVie, MSD Sharp & Dohme, Novartis and Omnicell, Tobias Warnecke has received lecturer and consulting honoraria from AbbVie, UCB Pharma, Archimedes, Bayer, Bial, Biogen, Desitin, Licher, Phagenesis, Pfizer, Teva, and Zambon.

Consent to participate and for publication

The study was not obtained as no patient data was used in this publication.

Ethical approval

was not obtained as no patient data were used in this publication

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rose, O., Happe, S., Huchtemann, T. et al. Enhancing medication therapy in Parkinson's disease by establishing an interprofessional network including pharmacists. Int J Clin Pharm 43, 441–448 (2021). https://doi.org/10.1007/s11096-021-01263-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-021-01263-w

Keywords

Search

Navigation